Huge congratulations to the Vitestro team on closing their Series B! Sonder Capital is proud to back a company redefining one of healthcare's most common procedures with autonomous robotic phlebotomy. Vitestro is building technology that can meaningfully improve access, consistency, and efficiency across care settings. Excited for what's ahead as the team continues scaling!
𝗪𝗲 𝗰𝗹𝗼𝘀𝗲𝗱 𝗮𝗻 𝗼𝘃𝗲𝗿𝘀𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲𝗱 𝗦𝗲𝗿𝗶𝗲𝘀 𝗕 𝗼𝗳 $𝟳𝟬𝗠 🎉 We’re proud to welcome new strategic investment from Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest Co., LTD, MGFO Private Investments, PGGM, Puma Venture Capital, and ROM Utrecht Region invest alongside existing investors Invest-NL, EIC - European Innovation Council Fund, Frederic Moll, NYBC Ventures, and Sonder Capital. “To close this financing reflects strong conviction in our mission to set a new standard in autonomous diagnostic blood collection.” Toon Overbeeke, CEO Read the full press release: https://lnkd.in/eVWn__P7 #SeriesB #MedTech #AutonomousPhlebotomy #Vitestro #Fundraising